Skip to content

Outcome of critically ill patients with abnormal sodium levels undergoing slow low efficiency daily dialysis therapy

A study to determine the outcome of patients with dysnatremia undergoing slow low efficiency dialysis (SLED) in ICU

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043320
Enrollment
100
Registered
2022-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N179- Acute kidney failure, unspecified

Interventions

None listed

Sponsors

King George Medical University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with age > 18 years with acute kidney injury (AKI) stage 2 and 3 as defined by KDIGO or Acute on Chronic Kidney disease for whom SLED was prescribed by the treating physician 2. Serum Na less than 135 mmol/L OR more than 145 mmol/L will be screened to be included in the study. 3. Patients with dysnatremia who undergo one session of SLED will be included only once in the study

Exclusion criteria

Exclusion criteria: 1. The patients whose pre dialysis Na is between 135-145 mmol/L 2. The patients who could not complete the SLED session scheduled for 8-10 hours 3. Patients who were end stage renal disease and received dialysis before enrolment

Design outcomes

Primary

MeasureTime frame
30 day all cause mortality after starting SLED in patients with dysnatremiaTimepoint: 30 days

Secondary

MeasureTime frame
To correlate the change in Na (Pre-post) dialysis to 30 day mortality To correlate the severity of dysnatremia with 30 day mortality Factors associated with 30 day mortalityTimepoint: 30th day

Countries

India

Contacts

Public ContactSai Saran

King George Medical University

saisaranpv@gmail.com08004505719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026